The European Medicines Agency (EMA) is looking for new data partners to collaborate with DARWIN EU® - the Data Analysis and Real-World Interrogation Network.
DARWIN EU® delivers real-world evidence from across Europe on diseases, populations, the use, safety and effectiveness of medicines. This enables EMA and national competent authorities to use these data whenever needed throughout the lifecycle of a medicinal product.
Public or private institutions that have access to real-world healthcare data can submit an expression of interest to become a potential new data partner in DARWIN EU®. The data will be used for studies to generate real-world evidence that will support scientific evaluations and regulatory decision making on medicines in Europe.
Deadline for expression of interest is 31 October 2023.
Information on how to express your interest is available on the DARWIN EU® Coordination Centre website.